The miR-192-EGR1/HOXB9 Loop Regulates Glioma Cell Stemness and Malignant Phenotypes by Promoting Their Mesenchymal...

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis.
• MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
• The specific role of miR-192 in glioma malignant phenotypes requires further elucidation.

Purpose of the Study:

• To investigate the regulatory effects of miR-192 on the malignant phenotypes of glioma cells.
• To identify the molecular mechanisms underlying miR-192's function in glioma.
• To explore the potential of miR-192 as a therapeutic target for glioma.

Main Methods:

• Quantitative PCR, Western blotting, and immunofluorescence were used to detect regulatory factors.
• Lentiviral plasmid transfection was employed to construct glioma cell models.
• Cell proliferation, invasion, migration, and stemness were assessed using CCK-8, colony formation, Transwell, scratch, and CD133+ GSC assays.
• A subcutaneous xenograft mouse model was established to evaluate tumor growth in vivo.

Main Results:

• MiR-192 expression was significantly reduced in glioma samples.
• MiR-192 directly downregulated EGR1 and HOXB9, forming a regulatory loop.
• Overexpression of miR-192 significantly decreased glioma cell proliferation, invasion, and migration.
• EGR1 or HOXB9 overexpression abrogated the inhibitory effects of miR-192.
• MiR-192 suppressed tumor growth, reduced stemness, and inhibited malignant phenotypes in vivo.

Conclusions:

• MiR-192 acts as a tumor suppressor in glioma by targeting the EGR1/HOXB9 axis.
• MiR-192 reduces glioma stemness and malignant phenotypes through the EGR1-HOXB9 loop.
• MiR-192 holds potential as a therapeutic agent for inhibiting glioma progression.